Validation of new ACR/EULAR 2022 classification criteria for anti-neutrophil cytoplasmic antibody–associated vasculitis

医学 肉芽肿伴多发性血管炎 显微镜下多血管炎 内科学 嗜酸性 血管炎 抗中性粒细胞胞浆抗体 痹症科 前瞻性队列研究 队列 病理 疾病
作者
Ken-Ei Sada,Shinya Kaname,Tomoaki Higuchi,Shunsuke Furuta,Kenji Nagasaka,Toshihiro Nanki,Naotake Tsuboi,Koichi Amano,Hiroaki Dobashi,Keiju Hiromura,Masashi Bando,Takashi Wada,Yoshihiro Arimura,Hirofumi Makino,Masayoshi Harigai
出处
期刊:Modern Rheumatology [Oxford University Press]
被引量:1
标识
DOI:10.1093/mr/road017
摘要

ABSTRACT Objective The objective of this study was to compare the American College of Rheumatology/European Alliance of Associations for Rheumatology 2022 criteria with the previous classification algorithm for anti-neutrophil cytoplasmic antibody–associated vasculitis. Methods We used data from two nationwide, prospective, inception cohort studies. The enrolled patients were classified as having eosinophilic granulomatosis with polyangiitis (EGPA), granulomatosis with polyangiitis (GPA), or microscopic polyangiitis (MPA) according to the new criteria; these criteria were compared with Watts’ algorithm. Results Among 477 patients, 10.7%, 9.9%, and 75.6% were classified as having EGPA, GPA, and MPA, respectively; 6.1% were unclassifiable. Three patients met both the EGPA and MPA criteria, and eight patients met both the GPA and MPA criteria. Of 78 patients with GPA classified using Watts’ algorithm, 27 (34.6%) patients were reclassified as having MPA. Ear, nose, and throat involvement was significantly less frequent in patients reclassified as having MPA than in those reclassified as having GPA. Of 73 patients unclassifiable using Watts’ algorithm, 62 were reclassified as having MPA. All patients reclassified as having MPA were myeloperoxidase-anti-neutrophil cytoplasmic antibody positive, and 46 had interstitial lung disease. Conclusion Although the American College of Rheumatology/European Alliance of Associations for Rheumatology 2022 criteria cause overlapping multiple criteria fulfilments in some patients, those items contribute to classifying unclassifiable patients using Watts’ algorithm into MPA.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
加肉发布了新的文献求助10
刚刚
alysia完成签到 ,获得积分10
1秒前
九天春雪发布了新的文献求助10
1秒前
vkey完成签到,获得积分10
2秒前
jixuzhuixun完成签到,获得积分10
2秒前
3秒前
3秒前
CipherSage的应助被王小明采纳,获得10
4秒前
矿泉水完成签到 ,获得积分10
4秒前
4秒前
4秒前
斯文败类的应助被Lu采纳,获得10
4秒前
唠叨的代真完成签到,获得积分10
5秒前
NexusExplorer的应助被晴空万里采纳,获得10
6秒前
6秒前
7秒前
狂野的小熊猫的应助被黄捷豹采纳,获得10
7秒前
sky完成签到,获得积分10
7秒前
寒冷天亦发布了新的文献求助10
7秒前
XS_QI发布了新的文献求助10
8秒前
顾矜的应助被观星采纳,获得10
8秒前
8秒前
linzhuo完成签到,获得积分10
8秒前
芋泥啵啵发布了新的文献求助10
8秒前
8秒前
星辰大海的应助被superZ采纳,获得10
8秒前
喜悦的项链完成签到,获得积分10
9秒前
9秒前
WX发布了新的文献求助10
9秒前
smcui发布了新的文献求助10
9秒前
wanci的应助被科研通管家采纳,获得10
9秒前
小东子完成签到,获得积分10
10秒前
10秒前
完美世界的应助被科研通管家采纳,获得10
10秒前
songjiatian发布了新的文献求助10
10秒前
FashionBoy的应助被科研通管家采纳,获得10
10秒前
乐乐的应助被科研通管家采纳,获得10
10秒前
10秒前
领导范儿的应助被科研通管家采纳,获得10
10秒前
Rainnnn完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184240
求助须知:如何正确求助?哪些是违规求助? 9573297
关于积分的说明 21830585
捐赠科研通 7781300
什么是DOI,文献DOI怎么找? 3434285
关于科研通互助平台的介绍 2558389
邀请新用户注册赠送积分活动 2480814